The price of shares in Imerys is close to a major medium term resistance level around 30.03 EUR. A correction phase over the short term appears to be the logical outcome. Investors should open a short trade and target the € 25.
As regards fundamentals, the enterprise value to sales ratio is at 0.98 for the current period. Therefore, the company is undervalued.
The company is one of the best yield companies with high dividend expectations.
The stock is close to a major daily resistance at EUR 30.03, which should be gotten rid of so as to gain new appreciation potential.
As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Analysts covering the stock have recently lowered their earnings forecast.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.
The underlying tendency is negative on the weekly chart below the resistance at 32.27 EUR
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.